Cargando…

COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management

Coronavirus disease 2019 (COVID‐19) is a systemic inflammatory condition with high mortality that may benefit from personalized medicine and high‐precision approaches. COVID‐19 patient plasma was analysed with targeted proteomics of 1161 proteins. Patients were monitored from Days 1 to 10 of their i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iosef, Cristiana, Martin, Claudio M., Slessarev, Marat, Gillio‐Meina, Carolina, Cepinskas, Gediminas, Han, Victor K. M., Fraser, Douglas D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806290/ https://www.ncbi.nlm.nih.gov/pubmed/36537107 http://dx.doi.org/10.1111/jcmm.17622

Ejemplares similares

Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function
por: Iosef, Cristiana, et al.
Publicado: (2023)

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020)

Novel plasma protein biomarkers from critically ill sepsis patients
por: Van Nynatten, Logan R., et al.
Publicado: (2022)

Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020)

Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
por: Fraser, Douglas D., et al.
Publicado: (2020)

Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets
por: Slessarev, Marat, et al.
Publicado: (2020)

Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021)

Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation
por: Fraser, Douglas D., et al.
Publicado: (2020)

Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation
por: Gill, Sean E., et al.
Publicado: (2020)

Endothelial Glycocalyx Degradation in Critical Illness and Injury
por: Patterson, Eric K., et al.
Publicado: (2022)

Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning
por: Patel, Maitray A., et al.
Publicado: (2023)

Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C)
por: Fraser, Douglas D., et al.
Publicado: (2021)

Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses
por: Fraser, Douglas D., et al.
Publicado: (2021)

Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients
por: Fraser, Douglas D., et al.
Publicado: (2022)

Inflammatory Response in Microvascular Endothelium in Sepsis: Role of Oxidants
por: Cepinskas, Gediminas, et al.
Publicado: (2008)

A Proteinase 3 Contribution to Juvenile Idiopathic Arthritis-Associated Cartilage Damage
por: Patterson, Eric K., et al.
Publicado: (2021)

High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
por: Di Narzo, Antonio F, et al.
Publicado: (2019)

Insulin‐like growth factors and their potential role in cardiac epigenetics
por: Iosef Husted, Cristiana, et al.
Publicado: (2016)

Resident work hours: why keeping the status quo may not be such a bad thing
por: Razik, Roshan, et al.
Publicado: (2013)

Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality
por: Cani, Erblin, et al.
Publicado: (2021)

Annexin A5 in Patients With Severe COVID-19 Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Feasibility Trial
por: Martin, Claudio M., et al.
Publicado: (2023)

Plasma proteomic signature of age in healthy humans
por: Tanaka, Toshiko, et al.
Publicado: (2018)

Frugal Innovation: Enabling Mechanical Ventilation During Coronavirus Disease 2019 Pandemic in Resource-Limited Settings
por: Dave, Chintan, et al.
Publicado: (2021)

Differentiation between Descending Thoracic Aortic Diseases using Machine Learning and Plasma Proteomic Signatures
por: Momenzadeh, Amanda, et al.
Publicado: (2023)

Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
por: Corlin, Laura, et al.
Publicado: (2020)

Plasma proteomic signatures predict dementia and cognitive impairment
por: Tanaka, Toshiko, et al.
Publicado: (2020)

Thermodynamic Signatures of Blood Plasma Proteome in Neurodegenerative Pathologies
por: Danailova, Avgustina, et al.
Publicado: (2023)

Proteomics reveals unique plasma signatures in constitutional thinness
por: Cominetti, Ornella, et al.
Publicado: (2022)

Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset
por: Johnstone, Daniel, et al.
Publicado: (2012)

PMN transendothelial migration decreases nuclear NFκB in IL-1β–activated endothelial cells: role of PECAM-1
por: Cepinskas, Gediminas, et al.
Publicado: (2003)

Hemodialysis Patients Have Impaired Cerebrovascular Reactivity to CO(2) Compared to Chronic Kidney Disease Patients and Healthy Controls: A Pilot Study
por: Slessarev, Marat, et al.
Publicado: (2021)

Impact of Graded Passive Cycling on Hemodynamics, Cerebral Blood Flow, and Cardiac Function in Septic ICU Patients
por: Chen, Jennifer, et al.
Publicado: (2020)

A Plasma Proteomic Signature of Skeletal Muscle Mitochondrial Function
por: Zampino, Marta, et al.
Publicado: (2020)

PLASMA PROTEOMIC SIGNATURE OF DECLINE IN GAIT SPEED AND GRIP STRENGTH
por: Liu, Xiaojuan, et al.
Publicado: (2022)

Plasma proteomic signature of decline in gait speed and grip strength
por: Liu, Xiaojuan, et al.
Publicado: (2022)

38 Plasma proteomic signature of motoric cognitive risk syndrome
por: Gomez, Gabriela T., et al.
Publicado: (2023)

Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease
por: Velez, Gabriel, et al.
Publicado: (2018)

Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia
por: Slessarev, Marat, et al.
Publicado: (2020)

Evidence-Based Considerations for the Design of an Open-Source Ventilator: A Systematic Review
por: Dave, Chintan, et al.
Publicado: (2022)

Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes
por: Chen, Bainian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_khlp6l4qesce32as842mr49kr3